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Summary
Bestrophin-1, an integral membrane protein encoded by the BEST1 gene, is localized predominantly to the basolateral membrane of the
retinal pigment epithelium. Mutations in the BEST1 gene have been associated with Best vitelliforme macular dystrophy (BMD), a
central retinopathy with autosomal dominant inheritance and variable penetrance. Over 120 disease-causing mutations are known, the
majority of which result in amino acid substitutions within four mutational hot-spot regions in the highly conserved N-terminal half of
the protein. Although initially thought to impair Cl– channel function, the molecular pathology of BEST1 mutations is still controversial.
We have analyzed the subcellular localization of 13 disease-associated BEST1 mutant proteins in polarized MDCK II cells, an
established model of apical to basolateral protein sorting. Immunostaining demonstrated that nine of the 13 mutant proteins failed to
integrate into the cell membrane. The defective proteins were predominantly retained in the cytoplasm, whereas wild-type bestrophin-1
revealed cell membrane localization. Functional analysis of I– fluxes in HEK-293 cells showed that all mutants exhibited a significant
reduction in anion conductance. Our data indicate that defective intracellular trafficking could be a common cause of BMD accompanied
by impaired anion conductance, representing a loss of anion channel function that is probably due to mistargeting of mutant protein.
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Introduction
Mutations in the BEST1 gene (MIM number 607854) have been
shown to result in several types of retinal degeneration, such as
Best vitelliforme macular dystrophy (BMD), autosomal dominant
vitreoretinochoroidopathy (ADVIRC), adult-onset macular
dystrophy (AVMD), autosomal recessive bestrophinopathy
(ARB) and retinitis pigmentosa (Boon et al., 2009; Davidson
et al., 2009; Xiao et al., 2010). Thus far, over 120 distinct
mutations have been identified and associated with the respective
disorder (see http://www-huge.uni-regensburg.de/BEST1_
database/). Nearly all the disease-associated changes are
missense mutations and predominantly affect the N-terminal
half of the BEST1 protein, termed bestrophin-1 (Boon et al.,
2009; Stohr et al., 2002).
Bestrophin-1 is strongly expressed in the retinal pigment
epithelium (RPE), where it mainly localizes to the basolateral
membrane (Gouras et al., 2009; Guziewicz et al., 2007;
Marmorstein et al., 2000; Mullins et al., 2007; Mullins et al.,
2005; Neussert et al., 2010). The RPE fulfills a multitude of
functions that are essential for excitability and the structural
integrity of the photoreceptors (Strauss, 2005). Mutations in
bestrophin-1 therefore probably result in altered RPE function,
subsequently contributing to disease. This sequence of events has
been demonstrated by ocular coherence tomography in BMD
patients (Pianta et al., 2003), post mortem eyes of BMD patients
(Bakall et al., 2007; Mullins et al., 2007; Weingeist et al., 1982)
and in canine (Guziewicz et al., 2007) and murine (Zhang et al.,
2010) animal models, which reveal alterations of the RPE such as
hypertrophy (Bakall et al., 2007; Guziewicz et al., 2007),
lipofuscin accumulation (Bakall et al., 2007; Guziewicz et al.,
2007; Mullins et al., 2005; Weingeist et al., 1982) and focal loss
of RPE cells (Bakall et al., 2007; Guziewicz et al., 2007; Mullins
et al., 2005). Patients affected with BMD characteristically have
an absent or reduced light-peak in the electro-oculogram (Arden
and Constable, 2006; Boon et al., 2009; Cross and Bard, 1974;
Ponjavic et al., 1999; Renner et al., 2005; Wabbels et al., 2004;
Weleber, 1989). Functionally, bestrophin-1 has been suggested to
play a dual role as an anion channel (Fischmeister and Hartzell,
2005; Hartzell et al., 2005; Hartzell et al., 2008; Jentsch et al.,
2002; Milenkovic et al., 2009; O’Driscoll et al., 2009; Qu et al.,
2004; Sun et al., 2002) and also as a regulator of intracellular free
Ca2+ homeostasis (Barro-Soria et al., 2010; Barro Soria et al.,
2009; Burgess et al., 2008; Hartzell et al., 2008; Marmorstein
et al., 2009; Neussert et al., 2010; Rosenthal et al., 2006; Yu et al.,
2008; Zhang et al., 2010). Subsequent reports have suggested that
bestrophin-1 also acts as HCO3
– channel (Qu and Hartzell, 2008),
and it might have a function as an ion channel in the membranes
of cell organelles (Barro-Soria et al., 2010; Neussert et al., 2010).
Although a plethora of disease-associated mutations in BEST1
are known, little information about the molecular mechanisms by
which these mutations affect bestrophin-1 function is available.
For example, most mutations appear to disrupt Cl– channel
function, although experimental evidence purely relies on cellular
overexpression of mutant protein, possibly reflecting spurious
artifacts well known for this type of in vitro approach (Clapham,
1998; Jentsch et al., 2002). Topological analysis of mutant
bestrophin-1 has suggested that a minor proportion of mutations
located in the transmembrane domains (TMDs) of bestrophin-1
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affect membrane topology by destabilizing TMD structure
(Milenkovic et al., 2007). Finally, a recent study has
demonstrated a mislocalized mutant bestrophin-1 associated
with retinitis pigmentosa (Davidson et al., 2009).
Numerous missense mutations in genes encoding integral
membrane proteins are associated with defective cellular
trafficking (Aridor and Hannan, 2000; Cheng et al., 1990;
Hume et al., 2009; Kausalya et al., 2006; Liu et al., 2001; Zhou
et al., 1998). Most integral membrane proteins are co-
translationally inserted into the membrane of the endoplasmic
reticulum (ER), from where they subsequently traffic through the
Golgi to the plasma membrane. This protein processing,
however, appears to be rather inefficient, even for wild-type
proteins. For instance, the cystic fibrosis transmembrane
conductance regulator (CFTR) assembles with ,50%
efficiency. In the case of mutant CFTR protein, the efficiency
of cellular membrane integration declines to ,25% that of the
wild-type protein (Kopito, 1999). Similar observations have been
made for a number of other integral membrane proteins, such as
epithelial sodium channel (ENaC), band 3 anion exchanger
(SLC4A1) and nicotinic acetylcholine receptor (CHRNA)
(Paulson et al., 1991; Rajan et al., 2001; Valentijn et al., 1998).
Protein folding and stability studies have demonstrated that a
single amino acid change is sufficient to reduce the folding
efficiency in a protein from 50% at body temperature to below
10% (Guerois et al., 2002). Because the most common
mechanism by which a single amino acid change leads to a
disease phenotype is disturbance of protein trafficking or folding
(Sanders and Myers, 2004), we examined the trafficking of
BMD-related mutants in polarized cells. Use of such a cell
system is particularly important for trafficking studies of
bestrophin-1, given that this protein localizes to the basolateral
membrane of the RPE, a highly polarized cellular monolayer
(Marmorstein et al., 2000).
Here, we have analyzed 13 disease-associated missense
mutations by studying the subcellular localization and anion
conductance of the encoded proteins. Anion permeability was
assessed by monitoring the fluorescence quench of YFP I152L by
I– ions, whereas the subcellular localization of mutant bestrophin-
1 was determined in polarized MDCK II cells, a standard model
to investigate cellular trafficking (Rodriguez-Boulan et al., 2005).
Our findings show that the majority of the mutant proteins are
retained in different intracellular compartments and are not
targeted to the plasma membrane. All mutants have a reduced
anion permeability, suggesting that defective intracellular
trafficking is the most common molecular basis for the BMD
phenotype.
Results
Expression and cellular localization of BMD-associated
mutant bestrophin-1 proteins
To investigate whether BMD-associated missense mutations affect
plasma membrane targeting, wild-type bestrophin-1 and 13
missense mutations, located in four mutational hot-spots of
bestrophin-1 (White et al., 2000), were generated by site-directed
mutagenesis and stably expressed in polarized MDCK II cells. The
additional pore-affecting mutation S79C (Qu et al., 2004) was also
examined (Fig. 1A). A mean transepithelial resistance (TER) of
194¡46V cm2, after correction for background resistance, verified
the integrity of the MDCK II cell monolayers, which were
subsequently used for immunostaining. All constructs were also
transiently expressed in HEK-293 cells. The wild-type and all
mutant bestrophin constructs had comparable expression levels
(Fig. 1B; supplementary material Fig. S1).
Polarized MDCK II cells expressing wild-type bestrophin-1
and the different bestrophin-1 mutants were co-stained for the
integral membrane protein monocarboxylate transporter 1 (MCT-
1). As expected, wild-type bestrophin-1 was targeted to the
basolateral membrane and showed strong [Pearson’s correlation
coefficient (PCC) 0.92] colocalization with the plasma membrane
marker MCT1 (Fig. 2A; Table 1). By contrast, nine out of the 13
bestrophin-1 mutants predominantly accumulated in the
cytoplasm and revealed no colocalization with the MCT1
membrane protein (PCC 0.09–0.17) (Fig. 2B–J; Table 1).
Several of the mutants (S79C, F80L, L82V and A243T) did
show predominant localization to the plasma membrane
(Fig. 3B–F; Table 1). However, compared with wild-type
bestrophin-1, the efficiency of this localization was reduced. A
Student’s t-test analysis of the PCCs for the BMD-associated
mutants and wild-type bestrophin-1 demonstrated a significant
Fig. 1. Predicted topology of human bestrophin-1 and relative location of
the disease-associated mutations analyzed in this study. (A) The mutated
residues are numbered as in the human bestrophin-1 and are shown in single-
letter code. The four mutational hot-spot regions identified by White et al.
(White et al., 2000) are also indicated. The effect of the respective mutation,
derived from colocalization studies (shown in Figs 2 and 3), on the
predominant distribution of bestrophin-1 is indicated as either being in the
plasma membrane (white background) or in intracellular compartments (black
background). (B) Western blot analysis showing expression of the full-length
bestrophin-1 constructs (67 kDa) in HEK-239 cells. b-Actin served as a
loading control. The level of protein expression of the bestrophin-1 constructs
were assessed by densitometry (supplementary material Fig. S1).
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Fig. 2. Colocalization of bestrophin-1 mutants with the plasma membrane marker MCT-1 in MDCK II cells. (A–J) Monolayers of MDCK II cells stably
expressing wild-type and various mutated bestrophin-1 constructs were stained with antibodies for human bestrophin-1 (left-hand panel, red) and MCT-1 (middle
panel, green). Merged images (right-hand panel) show the extent of colocalization of bestrophin-1 mutants and MCT-1. As shown, bestrophin-1 mutants are
predominantly targeted to the cytoplasm. The results of quantitative colocalization analysis are summarized in Table 1. Scale bars: 20 mm.
Table 1. Summary of steady-state localization of wild-type and mutant bestrophin-1 in MDCK II cells
Colocalization with
Bestrophin-1 form Surface expression Average PCC with MCT1 ER Golgi EEA1 LAMP1
Wild-type + 0.92
T6P – 0.13
L21V – 0.17 + *+ + –
W24C – 0.11
S79C + 0.71
F80L + 0.75
L82V + 0.61
R92S – 0.14 – *+ – –
R218C + 0.88
L224M – 0.11 + *+ + –
Y227N – 0.11
T237R – 0.15
A243T + 0.56
F305S – 0.09 – – *+ –
V311G – 0.12
Quantitative colocalization with the plasma membrane marker MCT1 was used to differentiate between surface and intracellular expression of bestrophin-1
(n>9). Values in bold indicate significant colocalization with MCT1; +, colocalization; –, no colocalization; *, predominant steady-state localization.
Journal of Cell Science 124 (17)2990
J
o
u
rn
a
l
o
f
C
e
ll
S
c
ie
n
c
e
difference (P,0.0001) between the subcellular localization of all
the mutants examined with the exception of mutant protein
R218C, which had an intracellular distribution highly similar to
wild-type bestrophin-1 (P.0.05) (Fig. 3E; Table 1).
Some of the mutants were studied in more detail by confocal
imaging to obtain vertical optical sections across MDCK II cell
monolayers. MDCK II monolayers were properly polarized as
demonstrated by co-staining with the tight-junction protein
zonula occludens-1 (ZO-1) and MCT-1 (Fig. 4A). In the
polarized monolayers, wild-type bestrophin-1 colocalized with
MCT1 to the basolateral part of the cell (Fig. 4B). By contrast,
the F305S mutant protein, which is mistargeted to the cytoplasm
(Fig. 2I), showed diffuse intracellular staining throughout the cell
(Fig. 4C). However, the R218C mutant protein, which seems not
to affect plasma membrane targeting (Fig. 3E), R218C almost
completely colocalized to the basolateral membranes with MCT1
(Fig. 4D).
Bestrophin-1 mutants with defective membrane targeting
localize to the Golgi complex, the ER or to early endosomes
Next, we aimed to identify intracellular compartments to which
bestrophin-1 mutants with predominant intracellular distribution
could localize. In order to clearly conclude about a possible
mechanism we concentrated on mutant bestrophin-1 with
predominant cytosolic localization. MDCK II cells stably
expressing the bestrophin-1 mutants L21V, R92S, L224M or
F305S, each one representing a mutational hot-spot of BEST1,
were co-stained with anti-bestrophin-1 antibody and antibodies
against the early endosome marker EEA1 (Fig. 5A), the Golgi
complex marker GM130 (Fig. 5B), the ER marker BIP (Fig. 5C)
and the lysosomal marker LAMP1 (Fig. 5D). All four mutants
showed no noticeable overlap with the lysosomal marker. By
contrast, mutants L21V, R92S and L224M extensively
colocalized with the Golgi marker. Mutants L21V, L224M and
F305S also colocalized with ER and early endosome markers.
Mutant F305S had the least colocalization with all the subcellular
markers tested. In order to more clearly identify the subcellular
compartments in which mutant bestrophin-1 proteins are trapped,
colocalization experiments were performed in subconfluent
MDCK II cells (supplementary material Fig. S2). These results
suggest that bestrophin-1 mutants mainly accumulate in the Golgi
complex and the ER.
BMD-associated mutant bestrophin-1 proteins show
decreased anion permeability of the cell membrane
To investigate the impact of missense mutations on the ability of
bestrophin-1 to increase anion permeability of the cell membrane,
I– fluxes were measured by halide-sensitive YFP I152L
fluorescence quench. As MDCK II cells are known to
endogenously express a large variety of ion channels including
Ca2+-dependent Cl– channels, these cells are largely unsuitable
for use in expression systems to study ion channel function (Lang
and Paulmichl, 1995; Rothstein and Mack, 1990; Shen et al.,
2002). Accordingly, HEK-293 cells were triple-transfected with
different bestrophin-1 constructs, YFP I152L and human P2Y
purinoceptor 2 receptor (P2Y2). In a first step, extracellular Cl–
ions were replaced by I–, which led to no quenching of the YFP
I152L fluorescence (Fig. 6A). To stimulate Ca2+-dependent
anion conductance of the cell membrane, cells were exposed to
100 mM ATP. In cells co-transfected with YFP I152L and P2Y2,
activation of endogenous anion channels contributed to a modest
decrease in the YFP I152L fluorescence. By contrast, cells
additionally transfected with wild-type bestrophin-1 showed a
strong quench in YFP I152L fluorescence when ATP was applied
indicating an influx of I– ions into the fluorescence. Thus, the
presence of bestrophin-1 increased the membrane permeability
for anions. The mutant bestrophin-1 constructs T6P, L21V,
Fig. 3. Colocalization of bestrophin-1 mutants with the plasma
membrane marker MCT-1 in MDCK II cells. (A–F) Monolayers of MDCK
II cells stably expressing wild-type and various mutated bestrophin-1
constructs were stained with antibodies for human bestrophin-1 (left-hand
panel, red) and MCT-1 (middle panel, green). Merged images (right-hand
panel) show the extent of colocalization of bestrophin-1 mutants and MCT-1.
As shown, bestrophin-1 mutants are predominantly targeted to the plasma
membrane. The results of quantitative colocalization analysis are summarized
in Table 1. Scale bars: 20 mm.
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L82V, Y227N and F305S showed a strongly reduced ability to
increase the anion permeability of transfected HEK-293 cells
(Fig. 6A,B) despite a expression level comparable to the wild-
type protein (Fig. 1B; supplementary material Fig. S1). By
contrast, expression of the other nine mutant bestrophin-1
constructs (W24C, S79C, F80L, R92S, R218C, L224M, T237R,
A243T and V311G) led to an anion permeability that was
significantly higher than that of cells transfected with YFP I152L
alone (P,0.05) (Fig. 6B).
Discussion
To gain further insight into the molecular mechanisms leading to
BMD pathology, we examined intracellular trafficking of mutant
bestrophin-1 proteins in polarized MDCK II cells. We analyzed
13 known disease-associated mutations and one mutation (S79C)
that has been predicted to change the properties of the anion
channel pore (Qu et al., 2004). Eight of these mutations (L21V,
W24C, F80L, L82V, L224M, T237R, F305S and V311G) were
functionally investigated for the first time, whereas none of the
known BMD mutations had been examined in polarized
epithelial cells previously. As a general theme, we found that
the mutants analyzed either failed to traffic to the cell membrane
or showed reduced efficiency to incorporate into the cell
membrane, with exception of mutation R218C, which was
targeted to the plasma membrane in a manner similar to the wild-
type protein. Interestingly, colocalization of wild-type
bestrophin-1 and MCT-1, a typical marker for the basolateral
membrane, was not entirely congruent, as a small proportion of
bestrophin-1 appeared to be associated with the lateral
membrane, but it also localized within the cytoplasm. Similar
observations have been made previously in other studies and
were thought to implicate bestrophin-1 in Ca2+ signaling by the
ER (Barro-Soria et al., 2010; Neussert et al., 2010). In a human
airway epithelial cell line endogenously expressing bestrophin-1,
wild-type bestrophin-1 had been previously found to be localized
in the endoplasmic reticulum by co-staining of bestrophin-1 and
calreticulin, calnexin or Stim-1 (stromal interacting molecule-1)
(Barro-Soria et al., 2010). Furthermore, by co-staining of
bestrophin-1 and b-catenin or pan-cadherin in native porcine
RPE, we identified a proportion of bestrophin-1 close to the
basolateral membrane but not integrated into the membrane
(Neussert et al., 2010).
A refined colocalization analysis with various subcellular
markers revealed that the mutants L21V, R92S, L224M and
F305S were partially retained in the Golgi complex, the
endoplasmic reticulum and in the early endosomes. This
suggests that mutant bestrophin-1 proteins are synthesized in
the ER and move to the Golgi complex where they fail to undergo
further processing. Proteins with missense mutations located on
regions of bestrophin-1 that reside in the cytoplasm (T6P, L21V,
W24C, L224M, Y227N, T237R, F305S and V311G) showed a
tendency to a more severe trafficking defect than mutations
located in the transmembranal areas of bestrophin-1 (S79C,
F80L, L82V and A243T). Thus, regions that localize to
cytoplasm seem to be important for proper processing.
Trafficking impairment might have been expected from
mutations T6P, L21V and W24C as they are located in the N-
terminus before the first transmembrane domain of bestrophin-1.
Often, the immediate N-terminal structures guide proteins into
vesicles, making trafficking to the cell membrane possible
(Denzer et al., 2000; von Heijne, 1996). The mutants Y227N,
T237R and V311G also showed disturbed trafficking, although
the precise mechanism remains elusive. We speculate that these
bestrophin-1 mutants also fail to process properly. In association
with single BEST1 mutations, a marked phenotypic variability
has been observed within families that show inheritance of single
BEST1 mutations (Boon et al., 2009). Thus we cannot draw
conclusions from the severity of trafficking defects to a possible
phenotype.
To further investigate the properties of the disease-associated
bestrophin-1 mutations, anion conductance was measured by
halide-sensitive YFP I152L assays in transfected HEK-293 cells.
Fig. 4. Z-stack image analysis of
representative bestrophin-1 mutants in
MDCK II cells. (A) Z-stack image analysis of
endogenous MCT-1 and ZO-1 in polarized
MDCK II cells grown on the filter. ZO-1 shows
apical localization, whereas MCT-1 localizes to
the basolateral membrane. (B) Wild-type
bestrophin-1 colocalizes with MCT-1 and is
targeted to the basolateral membrane. (C) The
F305S mutant is predominantly retained in the
cytoplasm. (D) The R218C mutant is targeted to
the plasma membrane, as shown from the
colocalization with MCT-1 (Table 1). Shown are
x–y and x–z projections of monolayers of MDCK
II cells. Scale bars: 20 mm.
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HEK-293 cells are an established model for studying
heterologously expressed ion channels (Varghese et al., 2006),
and most data on bestrophin-1 ion channel function have been
obtained with measurements in this cell line (Hartzell et al., 2008;
Pusch, 2004). To increase cytosolic free Ca2+, the cells were
additionally transfected with the human P2Y2 receptor and
stimulated with ATP. This is more physiological than the
alternative approach using Ca2+ ionophores because stimulation
of P2Y2 receptors involves activation of a physiological signal
transduction cascade including generation of either Ins(1,4,5)P3.
Analysis of activation mechanisms of Ca2+-dependent Cl–
channels in the RPE showed marked differences between the
application of either Ins(1,4,5)P3 or a Ca
2+ ionophore (Strauss
et al., 1996). As a main observation we found that all mutant
bestrophin-1 led to a strongly reduced increase in Ca2+-dependent
anion permeability; the observed I– quenches were significantly
smaller than those seen with wild-type bestrophin-1. This
observation is in accordance with patch-clamp data with the
same or similar mutations in bestrophin-1 (Qu et al., 2009; Sun
et al., 2002; Yu et al., 2006). Interestingly, nine of the mutant
bestrophin-1 proteins (W24C, S79C, F80L, R92S, R218C,
L224M, T237R, A243T and V311G) had significantly
increased Ca2+-dependent anion permeability compared with
those from cells transfected with YFP I152L plus hP2Y2 alone.
Thus, although activity was still much lower than with normal
bestrophin-1, these mutations still have residual ion-conductance
function.
Mutants S79C, F80L and R92S showed strongly reduced
ability to increase Ca2+-dependent anion permeability compared
with wild-type bestrophin-1, and mutant L82V failed to increase
Fig. 5. Subcellular localization of representative bestrophin-1 mutants. Bestrophin-1 constructs, with missense mutations selected from each mutational
hot-spot, were stably expressed in MDCK II cells and immunostained for bestrophin-1 (red), ZO-1 (blue) and the early endosome marker EEA1 (A), the
Golgi marker GM130 (B), the ER marker BIP (C) or the lysosomal marker LAMP1 (D) (green). Merged images show the extent of colocalization. The mutants
L21V, R92S and L224M extensively colocalized with GM130. The mutants L21V, L224M and F305S also colocalized with BIP and EEA1. F305S was least
colocalized with all the subcellular markers. Scale bars: 20 mm.
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the anion permeability. These mutations are located in the
putative pore region that localizes around amino acid positions
70–90. Interestingly, S79C, a mutant not known to be associated
with BMD, was utilized previously to demonstrate a putative
pore region in the homologue bestrophin-2 (Qu et al., 2004; Xiao
et al., 2010) but failed to increase the Ca2+-dependent anion
conductance in our experimental setup. The loss of I–
permeability of the mutant S79C is probably has a different
cause to that of pathogenic mutants with comparable trafficking
behavior because the mutation affects the putative pore.
Therefore, the loss of I– permeability might be explained by
strongly changed ion selectivity and a subsequent decrease in I–
conductance of the pore. Despite its ability to localize to the
plasma membrane, the R218C mutation failed to increase Ca2+-
dependent anion permeability in transfected HEK-293 cells.
Thus, it is probable that the main effect of this mutation is a loss
of anion channel function rather than a trafficking defect.
It should be mentioned that I– flux experiments do not permit
us to directly draw conclusions about ion channel properties of
bestrophin-1 and its mutant forms. As it discussed previously by
several groups, bestrophin-1 might have a function in the
cytosol to regulate intracellular Ca2+ signaling, with changes in
the anion conductance or permeability secondary to these
effects (Barro-Soria et al., 2010; Barro Soria et al., 2009;
Kunzelmann et al., 2009; Neussert et al., 2010; Zhang et al.,
2010). This was mainly concluded from experiments where
cells were transfected with bestrophin-1 together with the Ca2+-
dependent Cl– channel anoctamine-1 (Ano1). In these cases,
bestrophin-1 changed the membrane conductance for Cl– by
modulation of Ca2+ signaling and not by providing a membrane
conductance for Cl– by itself (Barro-Soria et al., 2010). Thus,
our observations on I– flux changes by bestrophin-1 and its
mutant forms could also reflect altered Ca2+ signaling in
response to P2Y2 receptor stimulation. Because the spatial
distribution of Ca2+ signals is of importance for their regulative
effects (Berridge et al., 2000; Petersen et al., 2001), it might
well be that an altered subcellular distribution of bestrophin-1
leads to altered spatial distribution of Ca2+ signals and a
subsequently altered activation of anion conductance.
Our data provide new insight into the molecular disease
pathology of bestrophin-1 mutations. It appears that mutations
located in the N-terminal region of bestrophin-1 result in a loss of
function by impaired trafficking to the cell membrane, by a loss
of pore function or by a combination of both. A loss of function
in the disease-associated mutant proteins could explain the
observed reduction of the light-peak in the electro-oculogram of
BMD patients (Hartzell et al., 2008; Marmorstein et al., 2009;
Xiao et al., 2010). The decreased anion conductance in the RPE
probably influences transepithelial transport of Cl– ions and water
and might also impair volume regulation. Both properties are
essential to RPE function and might cause disturbances in the
interaction of photoreceptor outer segments and the RPE
(Strauss, 2005).
Materials and Methods
Cell culture
HEK-293 (ATCC, cat# CRL-1573) and MDCK II (ATCC, cat# CCL-34) cells
were cultured in Dulbecco’s modified Eagle’s medium (DMEM) containing L-
glutamine, 4500 mg/l glucose and 110 mg/l sodium pyruvate. All media were
supplemented with 10% (v/v) fetal calf serum and 1% (v/v) penicillin-
streptomycin (PAA, Co¨lbe, Germany). Cells were cultured at 37 C˚, under an
atmosphere with a relative humidity of 95% and containing 5% CO2. HEK-293
cells were transfected with Lipofectamine 2000 transfection reagent (Invitrogen)
following the manufacturer’s instructions. MDCK II cells were transfected by
electroporation using ECM 830 (BTX Harvard Apparatus, Holliston, MA, USA).
Cells stably expressing wild-type and mutant bestrophin-1 were cultured for 2
weeks in a selection medium containing 500 mg/ml G418 (PAA). Pools of at least
three independent stable colonies were used for immunofluorescent studies.
Transepithelial electrical resistance
Transepithelial electrical resistance of the MDCK epithelial monolayers was
monitored with the Endohm apparatus (World Precision Instruments, Sarasota,
USA). MDCK II monolayers were grown on Transwell polycarbonate filters
(0.4 mm pore size), which consist of tissue-culture-treated polyester membranes
with an insert diameter of 12 mm and an effective growth area of 1 cm2. The upper
chamber (apical side) contained 0.5 ml medium and the lower one (basolateral
side) contained 1.8 ml medium. MDCK cells were seeded at a density of 105 cells
per ml and were grown to reach a stable TER, representing a confluent monolayer,
generally 5 days after seeding. The medium was changed every 2 days. The TER
was normalized to the area of the filter after removal of the background resistance
of a blank filter submerged in medium only. TER was measured in ohms cm2
(V cm2). The average TER measurement of polycarbonate filters in the absence of
a cell monolayer was 120 V cm2 (baseline).
Site-directed mutagenesis of BEST1
Full-length BEST1 was amplified by reverse transcriptase (RT)-PCR from mRNA
from human RPE and was directionally cloned into the pCDNA3 vector. Missense
mutations were generated on a full-length BEST1 cDNA template (GenBank
accession number, NM_004183; 1764 bp in length encoding 585 amino acids),
applying the QuikChange site-directed mutagenesis kit (Stratagene). The
constructs were made with the primer pair combinations given in supplementary
material Table S1. The final BEST1 constructs were fully sequenced to ensure the
targeted mutagenesis had occurred correctly and to exclude the presence of
Fig. 6. Anion permeability of HEK-293 cells expressing mutant and wild-
type bestrophin-1. (A) Purinergic activation of wild-type and selected
mutated bestrophin-1 constructs in HEK-293 cells. Activation of Ca2+
activated Cl– channels was measured by I– influx measurements using the
I–sensitive protein YFP I152L (YFPI52L). The figure shows examples of
single measurements from cells which either express YFP I152L with human
P2Y2 (hP2Y2) alone or YFP I152L with P2Y2 together with either wild-type
bestrophin-1 or the mutant forms. (B) A summary of the effects of ATP
stimulation on I– uptake in HEK-293 cells expressing various bestrophin-1
constructs. All mutant bestrophin-1 showed significantly decreased I–
permeability compared with that of cells expressing wild-type bestrophin-1.
However, the mutants W24C, S79C, F80L, R92S, R218C, L224M, T237R,
A243T and V311G showed a significantly larger I– permeability compared
with cells which express YFP I152L with P2Y2 alone. The number of cells is
given in the bar. *P,0.05.
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undesired sequence alterations. Sequencing reactions were performed with the Big
Dye terminator cycle sequencing kit version 3 or 3.1 (Applied Biosystems)
according to the manufacturer’s instructions and were analyzed in an ABI Prism
Model 3100 or 3730 sequencer (Applied Biosystems).
Cellular YFP I152L fluorescence measurement
HEK-293 cells were triple transfected using equal amount of each plasmid
(encoding YFP I152L, P2Y2–His6 receptor and the bestrophin-1 mutants). At 12–
16 hours after transfection, cells were seeded onto 18-mm diameter round glass
cover slips, and subsequent measurements were performed 36 hours after
transfection. The YFP I152L plasmid was kindly provided by Luis J.V. Galietta,
(Istituto Giannina Gaslini, Genova, Italy) (Galietta et al., 2001), and plasmid
encoding human P2Y2–His6 (Milenkovic et al., 2009) receptor was kindly
provided by Karl Kunzelmann (Institut fu¨r Physiologie, Regensburg, Germany).
Double immunostaining of the bestrophin-1 and P2Y2 receptor in HEK-293 cells,
which were used for the I– flux measurements, showed that majority of transfected
cells expressed both proteins (data not shown). YFP fluorescence was excited at
500 nm with a polychromatic illumination system for microscopic fluorescence
measurements VisiChrome (Visitron, Puchheim, Germany), and light emission
was measured at 535¡15 nm with a photomultiplier detector (SF, Zeiss,
Go¨ttingen, Germany). Quenching of YFP I152L fluorescence by I– influx was
induced by replacing 20 mM extracellular Cl– by I– ions (Galietta et al., 2001).
Images were acquired with a Coolsnap HQ CCD camera (Visitron, Puchheim,
Germany) and processed with the Metafluor software (Visitron). HEK-293 cells
were grown on 18-mm diameter round glass cover slips and mounted in an
imaging chamber maintained at room temperature. Cells were continuously
perfused at 4–5 ml per min with Ringer’s solution. Cells were exposed to 20 mM
I– by replacing NaCl with equimolar NaI and maintaining the total concentration of
NaCl plus NaI at 137 mM. Typically, measurements of fluorescence intensity were
performed in groups of 5–15 transfected HEK-293 cells and represent the average
intensity of all fluorescent cells within the selected area. Initial fluorescence values
were similar among cells transfected with different BEST1 cDNA constructs. The
decrease of cell fluorescence caused by addition of NaI was analyzed to calculate
anion transport. The fluorescence decay phase was fitted with an exponential
function to derive the maximal slope. Maximal slopes were converted into rates of
variation of intracellular anion concentration (in mM/s) using the equation: d[X–]/
dt5KX[d(F/F0)/dt], where [X
–] is the anion concentration, KX is the affinity
constant of YFP for a I– anion (Galietta et al., 2001) and F/F0 is the ratio of the cell
fluorescence at a given time compared with the initial fluorescence.
Quantitative colocalization analysis
To analyze colocalization quantitatively, MDCK II cells stably expressing wild-
type or mutant bestrophin-1 proteins were grown on filters and double labeled with
anti-bestrophin-1 and anti-MCT-1 antibodies. After subsequent incubation with
secondary antibodies conjugated with Alexa Fluor 488 and 543 (Invitrogen), filters
were mounted in confocal matrix (Micro Tech Lab, Graz, Austria), and then
examined with a confocal microscope LSM 510 (Zeiss, Go¨ttingen, Germany). All
images were taken as single sections in the z-plane. Double fluorescence for green
and red channels was recorded after excitation of an argon-krypton-neon laser at
wavelengths of 488 nm and 543 nm, respectively. Double-stained images were
obtained by sequential scanning for each channel to eliminate the crosstalk of
chromophores and to ensure reliable quantification of colocalization. Emission of
the different fluorophores was detected using the appropriate filter sets and multi-
channel acquisition. Quantitative analysis was performed with the software
package ImageJ (Abramoff et al., 2004). Pearson’s correlation coefficient (PCC)
was employed to evaluate colocalization according to Abramoff (Abramoff et al.,
2004). PCC is one of the standard techniques applied in pattern recognition for
matching one image to another in order to describe the correlation of the intensity
distributions between channels. It only takes into consideration the similarity of
shapes between two images, and does not depend upon image pixel intensity
values. Values of PCC range from –1 to 1, where –1 indicates no overlap and 1 is a
complete colocalization.
Immunohistochemistry
For the immunofluorescence experiments, MDCK II cells stably expressing wild-
type and mutant bestrophin-1 were grown on permeable supports (Costar
Transwells, Fischer Scientific, Schwerte, Germany). Cells were fixed for
10 minutes at room temperature with 4% (w/v) paraformaldehyde. After three
washing steps with 16 PBS, cells were permeabilized with blocking-
permeabilization solution [10% (v/v) normal goat serum, 0.5% (v/v) Triton X-
100 in 16 PBS] for 30 minutes. Cells were then labeled overnight with antibodies
against bestrophin-1 (ab2182, mouse monoclonal) (Marmorstein et al., 2000),
MCT-1, (ab35944, rabbit polyclonal), GM-130 (ab52649, rabbit polyclonal)
(Shaheen et al., 2009), GRP78 BIP (ab21685, rabbit polyclonal) (Dykstra et.al.,
2010) (all Abcam, Cambridge, UK), LAMP1 and EEA1 (both mouse monoclonal
antibodies, BD Biosciences, Heidelberg, Germany) diluted 1:100–1:500 in 2%
normal goat serum and 0.1% Triton X-100 in 16 PBS. Antibodies against ZO-1
(rat monoclonal, R26.4C, Developmental Studies Hybridoma Bank, University of
Iowa, USA) specifically stain tight junctions. After three additional washing steps,
cells were incubated for 1 hour with appropriate secondary antibodies (conjugated
with Alexa Fluor 488, Alexa Fluor 546 and Alexa Fluor 633; Invitrogen). Cells
were mounted in confocal matrix (Micro Tech Lab, Graz, Austria) and examined
with a confocal microscope LSM510 (Carl Zeiss, Go¨ttingen, Germany).
Western blotting
Protein lysates from transiently transfected HEK-293 cells were analyzed by SDS-
PAGE and western blotting (Milenkovic et al., 2009) with antibodies against
bestrophin-1 diluted 1:5000 (ab2182, Abcam, Cambridge, UK) and b-actin diluted
1:20,000 (Sigma). Quantification of protein expression was achieved by
densitometry analysis of western blots with the help of a digital imaging
analysis system (Chemiimager, Biozym, Oldendorf, Germany).
Data presentation and statistical analysis
All experiments were performed independently at least three times. Statistical
significance was tested with the unpaired Student’s t-tests, with P,0.05
considered significant.
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